2018年12月3日 New data on ASLAN003 presented at ASH Annual Meeting shows first signs of clinical activity of a DHODH Inhibitor in Acute Myeloid Leukaemia
2018年11月27日 ASLAN Pharmaceuticals announces acceptance of abstracts on new varlitinib data in BTC at ASCO Gastrointestinal Cancers Symposium
2018年11月8日 ASLAN Pharmaceuticals reports third quarter 2018 financial results and provides corporate update
2018年11月1日 ASLAN Pharmaceuticals to present new data on ASLAN003 at American Society of Hematology Annual Meeting
2018年10月30日 ASLAN CEO Dr Carl Firth to attend Jefferies London Healthcare Conference, 14 – 15 November 2018, London
2018年10月30日 ASLAN CEO Dr Carl Firth to present at Piper Jaffray 30th Annual Healthcare Conference, 27-29 November 2018, New York
2018年10月30日 ASLAN CEO Dr Carl Firth to present at BioCentury/BayHelix China Healthcare Summit, 12 – 14 November 2018, Shanghai
2018年10月22日 New data presented on ASLAN’s varlitinib at ESMO show promising results in heavily pre-treated BTC and CRC patients
2018年10月17日 ASLAN Pharmaceuticals enrolls first subject in phase 1 study for ASLAN004 in atopic dermatitis
2018年10月9日 ASLAN Pharmaceuticals to present posters on varlitinib and ASLAN003 at European Society For Medical Oncology Congress